Meeting
2019 Genitourinary Cancers Symposium
Performance of the 17-gene genomic prostate score test in men with prostate cancer (PCa) managed with active surveillance (AS): Results from the Canary Prostate Active Surveillance Study (PASS).
Authors
Daniel W. Lin
University of Washington, Seattle, WA
Daniel W. Lin , Yingye Zheng , Jesse McKenney , Marshall Brown , Ruixiao Lu , Michael Crager , Hilary Boyer , James D. Brooks , Atreya Dash , Michael Fabrizio , Martin Gleave , Michael A. Liss , Todd Matthew Morgan , Ian M Thompson , Andrew Wagner , Athanasios Tsiatis , Andrea Pingatore , H. Jeffrey Lawrence , Peter S Nelson , Lisa F Newcomb
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer,Prostate Cancer
Sub Track
Prostate Cancer - Advanced Disease
Citation
J Clin Oncol 37, 2019 (suppl 7S; abstr 262)
DOI
10.1200/JCO.2019.37.7_suppl.262
Abstract #
262
Poster Bd #
L19
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
Determining the impact of genomic classifier testing on patient-reported quality of life after prostatectomy: Results from the G-MINOR randomized trial.
First Author: Udit Singhal
Poster
2019 Genitourinary Cancers Symposium
Cribriform pattern, Genomic Prostate Score, and adverse pathology at radical prostatectomy in a cohort of prostate cancer patients initially on active surveillance.
First Author: Kyle Brian Zuniga
Poster
2019 Genitourinary Cancers Symposium
A 17-gene genomic prostate score as a predictor of adverse pathology for men on active surveillance.
First Author: Zachary Kornberg
Poster
2023 ASCO Genitourinary Cancers Symposium
A randomized phase II trial of neoadjuvant chemokine modulation in patients with localized prostate cancer undergoing radical prostatectomy.
First Author: Karan Jatwani